Skip to main content

Table 1 Summary of Patient-Reported Outcomes by timing of assessment

From: A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

PRO Baseline Assessment (at study entry)

Concept

Data source

 Generic Quality of Life

 EORTC QLQ-C30

 Disease specific Quality of Life

 EORTC QLQ-MY20

 Information Provision

 EORTC QLQ-INFO25

 Patient’s perception of involvement in treatment decisions

 Adapted Control Preference Scale

 Satisfaction with care, prognostic information and personal values

 Ad hoc questions

PRO follow-up assessments (3, 6, 12 and 24th month)

Concept

Data source

 Generic Quality of Life

 EORTC QLQ-C30

 Disease specific Quality of Life

 EORTC QLQ-MY20